Seres Therapeutics Inc (MCRB)

[Cosa]

I'm investing in the potential of an FDA approved drug that shows great efficacy. And the company's share price took an absolute beating since it's approval.

Not a fan of management as they should have had an offering in place prior to approval to take advantage of the higher price at the time. The cash runway is slim as R&D comes at a great expense. Also sales depends on another company or better worded as Seres revenue depends on another company which is quite scary.

In my opinion SER-155 has a high risk of failure. These people are extremely vulnerable and fighting for their lives. This drug would only help in one aspect of the patients overall condition. So it would be a really targeted market. The penetration into this market will be a difficult road if it makes it that far.

So overall investing here is very risky and buyout would be a blessing.

This is all my opinion. Good luck!